참고문헌
- Antonsson, B. and Martinou, J. C. 2000. The Bcl-2 protein family. Exp Cell Res 256, 50-57. https://doi.org/10.1006/excr.2000.4839
- Cheng, J. Q., Jiang, X., Fraser, M.,Li, M., Dan, H. C., Sun, M. and Tsang, B. K. 2002. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway, Drug Resist Update 5, 131-146. https://doi.org/10.1016/S1368-7646(02)00003-1
- Chiarugi, V., Magneli, L., Cinelli, M. and Basi, G. 1994. Apoptosis and the cell cycle. Cell Mol Biol Res 40, 603-612.
-
Choi, Y. H., Kong, K. R., Kim, Y. A., Jung,K. O., Kil, J. H., Rhee, S. H. and Park, K. Y. 2003. Induction of Bax and activation of caspases during
${\beta}$ -sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol 23, 1657-1661. - Choi, Y. H., Lee, S. J., Nguyen,P., Jang,J. S., Lee, J., Wu, M. L., Takano, E., Maki, M.,Henkart, P. A. and Trepel, J. B. 1997. Regulation of cyclin D1 by calpain protease. J Biol Chem 272, 28479-28484. https://doi.org/10.1074/jbc.272.45.28479
- Evans, V. G. 1993. Multiple pathways to apoptosis. Cell Biol Int 17, 461-476. https://doi.org/10.1006/cbir.1993.1087
- Gerschenson, L. E. and Rotello, R. J. 1992. Apoptosis: a different type of cell death. FASEB J 6, 2450-2455.
- Holcik, M., Gibsonand, H. and Korneluk, R. G. 2001. XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6, 253-261. https://doi.org/10.1023/A:1011379307472
- Jeong, Y. K., Park, J. U., Baek, H., Park, S. H., Kong, I. S., Kim, D. W. and Joo, W. H. 2001. Purification and biochemical characterization of a fibrinolytic enzyme from Bacillus subtilis BK-17. World J Microbiol Biotechnol 17, 89-92. https://doi.org/10.1023/A:1016685411809
- Jiang, C, Y., Yang, F. and Cheng, S. H. 2004. Fas ligand gene therapy for vascular intimal hyperplasia. Curr Gene Ther 4, 33-39. https://doi.org/10.2174/1566523044578022
- Jurgensmeier, J. M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D. and Reed, J. C. 1998. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95, 4997-5002. https://doi.org/10.1073/pnas.95.9.4997
- LaCasse, E. C., Baird, S., Korneluk, R. G. and MacKenzie, A. E. 1998. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17, 3247-3259.
- Lenaz, G., Bovina, C., Formiggini, G. and Castelli, G. P. 1999. Mitochondria, oxidative stress, and antioxidant defences. Acta Biochim Pol 46, 1-21.
- Lieberthal, W., Koh, J. S. and Levine, J. S. 1998. Necrosis and apoptosis in acute renal failure. Semin Nephrol 18, 505-518.
- Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B. and Reed, J. C. 1994. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805.
- Nagata, S. and Golstein, P. 1996. The Fas death factor. Science 267, 1449-1456.
- Rosse T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B. and Borner, C. 1998. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature 391, 496-499. https://doi.org/10.1038/35160
- Salvesen, G. S. and Duckett, C. S. 2002. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3, 401-410. https://doi.org/10.1038/nrm830
- Schultz, D. R. and Harrington, Jr. W. J. 2003. Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 32, 345-369. https://doi.org/10.1053/sarh.2003.50005
- Shi, L., Nishioka, W. K., Th'ng, J., Bradbury, E. M., Litchfield, D. W. and Greenberg, A. H. 1994. Premature p34cdc2 activation required for apoptosis. Science 263, 1143-1145. https://doi.org/10.1126/science.8108732
- Zimmermann, K. C., Bonzon, C. and Green, D. R. 2001. The machinery of programmed cell death. Pharmacol Ther 92, 57-70. https://doi.org/10.1016/S0163-7258(01)00159-0